OBSERVE MEDICAL OBSRV NON-REGULATORY PRESS RELEASES

Observe Medical - Company presentation with trading update

10. November 2026 kl. 11:35

Oslo, 10 November 2026.

With reference to today's webcast, please find enclosed the presentation.

Highlights:

- Continuous sales growth - up 51%* year to date, driven by value-based products - Order intake accelerating - up 49%* year to date, with NOK 5.7 million in November alone - Go-to-market model shaped and proven, scaling has started - focus markets have grown by up to 700%, scaling through increased sales capacity and competence - Establishing clinical leadership - two publications on UnoMeter Safeti Max by Karolinska University Hospital clinicians; now executing towards clinical and financial decision makers - UnoMeter Sippi: first step into the US - the ICU team at Northwell Health has asked to be the first users in the US

*Growth in EUR. Unaudited figures; see the presentation for details.

A recording of the presentation is also available at:Hegnar Media - Observe Medical Trading update november 2026 (https://qcnl.tv/p/NAjGJcoaq4K7jHYMejf9xQ)

For further information, please contact:

Jørgen Mann, CEO Observe Medical Mobile: +45 408 67 558 E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical Mobile: +47 958 12 765 E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at observemedical.com (http://www.observemedical.com) and follow us at LinkedIn (https://www.linkedin.com/company/observe-medical/)for the latest updates